Chemotherapy Use, Performance Status, and Quality of Life at the End of Life

Author:

Prigerson Holly G.1,Bao Yuhua2,Shah Manish A.3,Paulk M. Elizabeth4,LeBlanc Thomas W.5,Schneider Bryan J.6,Garrido Melissa M.7,Reid M. Carrington8,Berlin David A.9,Adelson Kerin B.10,Neugut Alfred I.11,Maciejewski Paul K.12

Affiliation:

1. Center for Research on End-of-Life Care, Weill Cornell Medical College, New York, New York2Division of Geriatrics and Palliative Medicine, Department of Medicine, Weill Cornell Medical College, New York, New York

2. Department of Healthcare Policy and Research, Weill Cornell Medical College, New York, New York

3. Meyer Cancer Center of Weill Cornell Medical College, Medical Oncology/Solid Tumor Program, New York, New York

4. Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas

5. Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, North Carolina

6. University of Michigan Comprehensive Cancer Center, Ann Arbor

7. James J. Peters VA Medical Center, Bronx, New York9Brookdale Department of Geriatrics and Palliative Medicine, Icahn School of Medicine at Mount Sinai, New York, New York

8. Division of Geriatrics and Palliative Medicine, Department of Medicine, Weill Cornell Medical College, New York, New York

9. Department of Medicine, Medical Intensive Care Unit, New York Presbyterian Hospital-Weill Cornell Center, New York

10. Smilow Cancer Hospital at Yale-New Haven, Yale University School of Medicine, New Haven, Connecticut

11. Department of Medicine and Herbert Irving Comprehensive Cancer Center, College of Physicians and Surgeons, Columbia University, New York, New York12Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York

12. Center for Research on End-of-Life Care, Weill Cornell Medical College, New York, New York14Department of Radiology, Weill Cornell Medical College, New York, New York

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3